Granulocyte colony-stimulating factor-induced comobilization of CD4- CD8- T cells and hematopoietic progenitor cells (CD34+) in the blood of normal donors

Blood

Volumn 89, Issue 7, 1997, Pages 2586-2595

  Kusnierz Glaz, Claus R ^a   Still, Beverley J ^a   Amano, Masahiko ^a   Zukor, Jazil D ^a   Negrin, Robert S ^a   Blume, Karl G ^a   Strober, Samuel ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; BLOOD DONOR; CELL DENSITY; CELL FRACTIONATION; CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKAPHERESIS; LIGHT SCATTERING; MIXED LEUKOCYTE CULTURE; NORMAL HUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0030902240     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.7.2586     Document Type: Article

References (20)

1. Siena S, Bregni M, Brando B, Ravagnani F, Bonadonna G, Gianni AM: Circulation of C34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous human granulocyte-macrophage colony-stimulating factor. Blood 74:1905, 1989
2. Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, Mcgrath KM, Mortstyn G, Fox RM: Effect of peripheral-blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640, 1992
3. Chao NJ, Schriber JR, Grimes K, Long GD, Negrin RS, Raimondi CM, Horning SJ, Brown SO, Miller L, Blume KG: Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high dose chemotherapy. Blood 81:2031, 1993
4. Korbling M, Przepiorka D, Huh YO, Engel H, van Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood 85:1659, 1995
5. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995
6. Schmitz N, Dreger P, Suttorp M, Rohwedder EB, Haferlach T, Loffler H, Hunter A, Russell NH: Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 85:1666, 1995
7. +) cells by density gradients with sufficient yields for transplantation. Exp Hematol 23:1024, 1995
8. Pettengell R, Luft T, Henschler R, Hows JM, Dexter TM, Ryder D, Testa NG: Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood and blood stem cells. Blood 84:3653, 1994
9. + Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 86:2842, 1995
10. Anderlini P, Przepiorka D, Khouri I, van Besien K, Mehra R, Giralt S, Gajewski J, Cleary K, Champlin R, Andersson B, Korbling M: Chronic graft-vs-host disease (GVHD) after allogeneic marrow or blood stem cell transplantation. Blood 86:109a, 1995 (abstr, suppl 1)
11. Pan L, Delmonte J Jr, Jalonen CK, Ferrara JLM: Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 86:4422, 1995
12. -αβ bone marrow T cells with suppressor activity. J Immunol 148:373, 1992
13. Palathumpat V, Dejbakhsh-Jones S, Holm B, Strober S: Different subsets of T cells in the adult mouse bone marrow and spleen induce or suppress acute graft versus host disease. J Immunol 149:808, 1992
14. Schmidt-Wolf I, Dejbakhsh-Jones S, Holm B, Strober S: T cell subsets and suppressor cells in human bone marrow. Blood 80:3242, 1992
15. Ierino FL, Hulett MD, McKenzie IFC, Hogarth PM: Mapping epitopes of human FcγR II (CDw32) with monoclonal antibodies and recombinant receptors. J Immunol 150:1794, 1993
16. Negrin RS, Kusnierz-Glaz CR, Still BJ, Schriber JR, Chao NJ, Long GD, Hoyle C, Hu WW, Horning SJ, Brown BW, Blume KG, Strober S: Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma. Blood 85:3334, 1995
17. Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Demuynck HMS, Link H, Zander A, Barge A, Borkett K: Randomized trial of filgrastim-mobilized peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients. Lancet 347:353, 1996
18. Palathumpat V, Holm B, Dejbakhsh-Jones S, Strober S: Treatment of BCL, leukemia by transplantation of low density fractions of allogeneic bone marrow and spleen cells. J Immunol 148:3319, 1992
19. Dejbakhsh-Jones S, Jerabek L, Weissman IL, Strober S: Extrathymic maturation of αβ T cells from hemopoietic stem cells. J Immunol 155:3338, 1995
20. Strober S, Palathumpat V, Schwadron R, Hertel-Wulff B: Cloned natural suppressor cells prevent lethal graft versus host disease. J Immunol 138:699, 1987